GT
CLLS

Glenmede Trust’s Cellectis CLLS Stock Holding History

Glenmede Trust’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed – – 3027
2019
Q3 		$0 Hold
50
– – ﹤0.01% 3024
2019
Q2 		$0 Hold
50
– – ﹤0.01% 3080
2019
Q1 		$0 Sell
50
-100
-67% -$1.77K ﹤0.01% 3071
2018
Q4 		$2 Buy
+150
New +$3.48K ﹤0.01% 2750
2018
Q2 		– Sell
-150
Closed -$4K – 1979
2018
Q1 		$4K Hold
150
– – ﹤0.01% 2442
2017
Q4 		$4K Hold
150
– – ﹤0.01% 2442
2017
Q3 		$4K Hold
150
– – ﹤0.01% 2394
2017
Q2 		$3K Hold
150
– – ﹤0.01% 2389
2017
Q1 		$3K Buy
+150
New +$3.15K ﹤0.01% 2389

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Glenmede Trust's CLLS Position: Q4 2019 in Review

Glenmede Trust sold out of Cellectis (CLLS) in Q4 2019, closing a stake of 50 shares.

Glenmede Trust first reported a position in CLLS in Q1 2017 and held it in 9 quarters. The position peaked at $4K in Q1 2018. 60 funds tracked by Wall St. Rank hold CLLS as of Q4 2019.

  • Glenmede Trust reported no remaining Cellectis position as of Q4 2019 after selling out during the quarter.
  • Glenmede Trust sold 50 Cellectis shares in Q4 2019.
  • Glenmede Trust first reported a position in Cellectis in Q1 2017 and held it in 9 quarters.
  • Glenmede Trust's Cellectis position peaked at $4K in Q1 2018.
  • 60 funds tracked by Wall St. Rank held Cellectis as of Q4 2019.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.